title: Characterization of human lung cancer cells resistant to 4'-O-demethyl-4beta-(2"-nitro-4"-fluoroanilino)-4-desoxypodophyllotoxin , a unique compound in the epipodophyllotoxin antitumor class.
abstract: A new semi-synthetic podophyllotoxin derivative, 4'-O-demethyl-4beta-2"-nitro-4"-fluoroanilino)-4-desoxypo dophyllotoxin (compound 1), an analog of GL-331 (compound 2), is a potent and broad-spectrum inhibitor of cultured human cancer and drug-resistant cell growth. In general, 4'-demethylepipodophyllotoxin analogs, including 2, exert anti-tumor activity by targeting the nuclear enzyme DNA topoisomerase II, but 1 is not an enzyme inhibitor. Unlike the cytotoxic activity of compound 2, cell killing by 1 is dose-limiting and a significant fraction of cells (30-40%) survive treatment. As an approach to investigate mechanism of action, 1-resistant A549 (human lung cancer) sub-lines were selected and characterized. Results of the work show that 1-resistant cells: (i) are moderately cross-resistant (2- to 3-fold) to various cytotoxic drugs via a P-glycoprotein-independent mechanism, (ii) have an altered growth habit, (iii) are deficient in normal attachment on plastic and collagen substrata, and (iv) have an altered plasma membrane protein composition including several proteins in the 140->200 kDa molecular mass range and a doublet of phosphoserine-containing proteins of about 135 kDa. Since 1 treatment of cells affects neither cellular attachment or membrane-protein phosphorylation, the changes observed in 1-resistant cells are interpreted as a survival response to drug action.
authors.affiliation: Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina at Chapel Hill, 27599, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Tachibana
authors.forename: X K
authors.initials: XK
authors.lastname: Zhu
authors.forename: P
authors.initials: P
authors.lastname: Krishnan
authors.forename: K H
authors.initials: KH
authors.lastname: Lee
authors.forename: K F
authors.initials: KF
authors.lastname: Bastow
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D004347:Drug Interactions; D019008:Drug Resistance, Neoplasm; D019450:Genes, MDR / Q000502:physiology; D006801:Humans; D007624:KB Cells; D008175:Lung Neoplasms / Q000473:pathology; D008565:Membrane Proteins / Q000187:drug effects / Q000378:metabolism; D010766:Phosphorylation; D011034:Podophyllotoxin / Q000031:analogs & derivatives / Q000494:pharmacology*; D059004:Topoisomerase I Inhibitors; D014407:Tumor Cells, Cultured; D014700:Verapamil / Q000494:pharmacology
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000972:Antineoplastic Agents, Phytogenic; D002121:Calcium Channel Blockers; D008565:Membrane Proteins; D059004:Topoisomerase I Inhibitors; D014700:Verapamil; D011034:Podophyllotoxin